Evidence map›Paper›PMID 39290158›Full record

ArticleThe Journal of clinical endocrinology and metabolism2025

Expanding the Spectrum of Endocrine Abnormalities Associated With SOX11-related Disorders.

Bang Sun, Maria I Stamou, Sara L Stockman, Mark B Campbell, Lacey Plummer, Kathryn B Salnikov, Leman Damla Kotan, A Kemal Topaloglu, Fuki M Hisama, Erica E Davis and 2 more

Abstract read
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Expanding the Spectrum of Endocrine Abnormalities Associated With SOX11-related Disorders.The Journal of clinical endocrinology and metabolism · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Bang SunReproductive Endocrine Unit, Endocrine Division, Massachusetts General Hospital, Boston, MA 02114, USA.
Maria I StamouReproductive Endocrine Unit, Endocrine Division, Massachusetts General Hospital, Boston, MA 02114, USA.
Sara L StockmanReproductive Endocrine Unit, Endocrine Division, Massachusetts General Hospital, Boston, MA 02114, USA.
Mark B CampbellReproductive Endocrine Unit, Endocrine Division, Massachusetts General Hospital, Boston, MA 02114, USA.
Lacey PlummerReproductive Endocrine Unit, Endocrine Division, Massachusetts General Hospital, Boston, MA 02114, USA.
Kathryn B SalnikovReproductive Endocrine Unit, Endocrine Division, Massachusetts General Hospital, Boston, MA 02114, USA.
Leman Damla KotanDivision of Pediatric Endocrinology, Faculty of Medicine, Cukurova University, Adana, 01250, Turkey.
A Kemal TopalogluDivision of Pediatric Endocrinology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02113, USA.
Fuki M HisamaDivision of Medical Genetics, Department of Medicine, University of Washington School of Medicine, Seattle, WA 98195, USA.
Erica E DavisAdvanced Center for Translational and Genetic Medicine, Stanley Manne Children's Research Institute, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL 60611, USA.
Stephanie B SeminaraReproductive Endocrine Unit, Endocrine Division, Massachusetts General Hospital, Boston, MA 02114, USA.
Ravikumar BalasubramanianReproductive Endocrine Unit, Endocrine Division, Massachusetts General Hospital, Boston, MA 02114, USA.ORCID 0000-0001-6008-5585

Funding

The Massachusetts General Hospital Harvard Center for Reproductive MedicineP50HD104224 · NICHD · MASSACHUSETTS GENERAL HOSPITAL · PI TALKOWSKI, MICHAEL E · 2021 to 2025
$7.8M
Towards Curative Therapies for Hypogonadotropic DiseasesR37HD043341 · NICHD · MASSACHUSETTS GENERAL HOSPITAL · PI Stephanie Beth Seminara · 2020 to 2026
$5.8M
Dissection of the Molecular Basis of Pleiotropy Between GnRH Neuronal Development and Cranial Suture FusionR01DE031452 · NIDCR · MASSACHUSETTS GENERAL HOSPITAL · PI Erica Ellen Davis, Stephanie Beth Seminara · 2022 to 2026
$3.9M
Integrative Approaches to Decipher Genetic Determinants of Disease Penetrance in Prokineticin 2 Pathway Related Human Reproductive DisordersR01HD096324 · NICHD · MASSACHUSETTS GENERAL HOSPITAL · PI BALASUBRAMANIAN, RAVIKUMAR · 2018 to 2022
$1.7M
Deciphering the Role of Copy Number Variants in Neuroendocrine Disorders of InfertilityF32HD108873 · NICHD · MASSACHUSETTS GENERAL HOSPITAL · PI STAMOU, MARIA · 2022 to 2024
$233k
FDA HHS R01 FD007843NICHD NIH HHS F32 HD108873NICHD NIH HHS P50 HD104224NICHD NIH HHS R01 HD096324NICHD NIH HHS R37 HD043341NIDCR NIH HHS R01 DE031452
6 · The paper itself

Abstract

contextSOX11 variants cause Coffin-Siris syndrome, characterized by developmental delay, hypogonadotropic hypogonadism, and skeletal and facial defects.

objectiveTo examine the contribution of SOX11 variants to the pathogenesis of idiopathic hypogonadotropic hypogonadism (IHH), a disorder caused by hypothalamic GnRH deficiency.

settingThe Reproductive Endocrine Unit and the Pediatric Endocrinology Division, Massachusetts General Hospital. PATIENTS OR OTHER

participantsA cohort of 1810 unrelated IHH probands.

interventionsExome sequencing data from the entire cohort were examined for SOX11 rare single nucleotide variants (SNVs) (minor allele frequency in the gnomAD database <0.1%). Rare SOX11 variant association testing was performed between the IHH and gnomAD population. Phenotyping of individuals harboring pathogenic/likely pathogenic SNVs (determined by the American College of Medical Genetics criteria) was performed. MAIN OUTCOMES/

resultsFour pathogenic SOX11 SNVs were identified in 5 IHH probands. The IHH cohort was enriched for SOX11 protein truncating SNVs (frameshift/nonsense) across the entire protein (2 SNVs in 3 IHH cases [p.S303X (de novo); p.S345Afs*13]; P = .0004981) and for SOX11 missense SNVs within the SOX11 high-mobility group domain (2 SNVs in 2 IHH cases p.G84D [de novo]; p.P114S; P = .00313922). The phenotypic spectrum of SOX11 variant carriers revealed additional endocrine defects including anosmic and normosmic forms of IHH, GH deficiency, pituitary and hypothalamic structural defects, and hypothyroidism. A pathogenic SOX11 SNV was also identified in a patient with functional hypogonadotropic hypogonadism (p.R100Q). Coffin-Siris syndrome-associated features were present in 4/5 probands.

conclusionDeleterious SOX11 variants cause IHH and other pituitary hormone deficiencies, suggesting that the human SOX11-associated disorder may stem from both hypothalamic and pituitary level defects.

Indexed as

Abnormalities, MultipleEndocrine System DiseasesHypogonadismSOXC Transcription FactorsAdolescentAdultChildChild, PreschoolCohort StudiesExome SequencingFemaleHumansMalePhenotypePolymorphism, Single NucleotideSOX11 protein, humanSOXC Transcription Factorsgeneticshypogonadotropic hypogonadismhypothalamuspituitarySOX11

Identifiers

PMID39290158
PMCPMC12168065

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.